Assessing the SCLC Treatment Landscape Biochemical Recurrence in Prostate Cancer Insights Into Treatment Challenges in HER2+ Breast Cancer MRD in Early-Stage CRC NCCN Guidelines Update for HR+ Breast Cancer Register: Updates in HER2+ Breast Cancer from ASCO and Implications for Practice

Assessing the SCLC Treatment LandscapeBiochemical Recurrence in Prostate Cancer Insights Into Treatment Challenges in HER2+ Breast Cancer MRD in Early-Stage CRCNCCN Guidelines Update for HR+ Breast CancerRegister: Updates in HER2+ Breast Cancer from ASCO and Implications for Practice

Clinical

View More Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

All News NP/PA Practice Management Technology

All NewsNP/PAPractice ManagementTechnology

Media

Around the Practice Clinical Consult Enduring Webinars Expert Interviews Medical World News OncView Podcasts Readout 360 Tumor Board Series

Around the PracticeClinical ConsultEnduring WebinarsExpert InterviewsMedical World NewsOncViewPodcastsReadout 360Tumor Board Series

Conferences

Publications

About Oncology Journal MBCC Abstract Supplement Oncology Journal

About Oncology JournalMBCC Abstract SupplementOncology Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Image IQ Polls Quizzes Slideshows Sponsored Toolkits

Image IQPollsQuizzesSlideshowsSponsoredToolkits

eNewsletter Print Subscription

eNewsletterPrint Subscription

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

Assessing the SCLC Treatment Landscape
Biochemical Recurrence in Prostate Cancer
Insights Into Treatment Challenges in HER2+ Breast Cancer
MRD in Early-Stage CRC
NCCN Guidelines Update for HR+ Breast Cancer
Register: Updates in HER2+ Breast Cancer from ASCO and Implications for Practice

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Ernest L. Mazzaferri, MD, MACP | Authors

Articles

What Is the Optimal Initial Treatment of Low-Risk Papillary Thyroid Cancer (and Why Is It Controversial)?

June 11, 2009

Patients with papillary thyroid cancer typically undergo a triad of consecutive initial treatments, comprising surgery, radioiodine therapy, and thyroid hormone suppression of serum thyrotropin (thyroid-stimulating hormone, or TSH).